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Stroke has limited treatment options, demanding a vigorous search for new therapeutic
strategies. Initial enthusiasm to stimulate restorative processes in the ischemic brain
by means of cell-based therapies has meanwhile converted into a more balanced view
recognizing impediments related to unfavorable environments that are in part related to
aging processes. Since stroke afﬂicts mostly the elderly, it is highly desirable and clinically
important to test the efﬁcacy of cell therapies in aged brain microenvironments. Although
widely believed to be refractory to regeneration, recent studies using both neural precursor
cells and bone marrow-derived mesenchymal stem cells for stroke therapy suggest that
the aged rat brain is not refractory to cell-based therapy, and that it also supports plasticity
and remodeling. Yet, important differences exist in the aged compared with young brain,
i.e., the accelerated progression of ischemic injury to brain infarction, the reduced rate of
endogenous neurogenesis and the delayed initiation of neurological recovery. Pitfalls in the
development of cell-based therapies may also be related to age-associated comorbidities,
e.g., diabetes or hyperlipidemia, which may result in maladaptive or compromised brain
remodeling, respectively. These age-related aspects should be carefully considered in the
clinical translation of restorative therapies.
Keywords: aging, stroke, cell therapy, comorbidities, neurogenesis
AGE AS MAJOR RISK FACTOR FOR STROKE
Stroke is a highly prevalent disease, which represents the second
most common cause of death in Europe, and the third most com-
mon cause of death in the United States and Canada (Lloyd-Jones
et al., 2010; Roger et al., 2012). Age is the principal non-modiﬁable
risk factor for stroke. The incidence of stroke increases signiﬁ-
cantly with age in both men and women, with half of all strokes
occurring in subjects over 75 years of age, and one-third in sub-
jects over 85 years of age (Roger et al., 2012). Although the entire
older population is at risk of stroke, there are important sex dif-
ferences in stroke incidence. The incidence of stroke is higher in
men than women up to 75 years old, equilibrates in subjects aged
75–84 years, and gets higher in women than men aged 85 years or
older (Roger et al., 2012). Thismay be attributed to sex-related dif-
ferences in risk factor proﬁles, resulting in a higher life expectancy
in women than men. Importantly, age-associated changes show
great variability among individuals, which are modiﬁed by genetic
and long-term lifestyle factors (Tacutu et al., 2010, 2011).
STROKE MODELS USING AGED ANIMALS ARE CLINICALLY
MORE RELEVANT
Effects of age and sex on stroke incidence, functional neurological
recovery and stroke mortality have been shown both in humans
and in animal models (Badan et al., 2003; Buchhold et al., 2007;
Gokcay et al., 2011). Speciﬁcally, the age-dependent acceleration in
the progression of ischemic tissue into infarction strongly suggests
that age is a biological marker for the variability in stroke outcome
(Ay et al., 2005).
Over the past 10 years, a variety of models of middle cerebral
artery occlusion (MCAO) have been established in rodents (Baci-
galuppi et al., 2010). MCAO in aged rodents has been produced
with permanent occlusion or transient occlusion for 30–120 min
using (i) non-localized photothrombosis achieved by irradiation
of the right carotid artery (Futrell et al., 1991); (ii) thermocoagula-
tion after microcraniotomy (Davis et al., 1995); (iii) intraluminal
using a silicon-coated suture (Sutherland et al., 1996); (iv) a hook
attached to a micromanipulator (Popa-Wagner et al., 1998); (v)
cauterization (Katsman et al., 2003); (vi) photothrombosis (Zhao
et al., 2005); (vii) injection of a thrombus via the external carotid
artery (Zhang et al., 2005, 2013; Dinapoli et al., 2006); or (viii)
endothelin-1 injection (Soleman et al., 2010). These models differ
in the localization and size of the ischemic lesions, as well as in
mortality rates following surgery, as summarized in Table 1.
Since focal cerebral ischemia is technically difﬁcult to perform
in very old rodents and since in humans stroke is highly preva-
lent in late middle aged (60–70 years old) subjects (Feigin et al.,
2003), middle aged rodents may represent a reasonable choice for
stroke studies (Popa-Wagner et al., 2007). In the following, spe-
ciﬁc responses of the aged brain to ischemic stroke and cell-based
therapy are outlined. Results from cell transplantation studies in
aged rodents are summarized in Table 2.
SPONTANEOUS STROKE RECOVERY IN AGED PATIENTS AND
ANIMALS
Neurological recovery is thought to occur via recruitment of
neighboring neuronal circuitries (Hallett, 2001; Hermann and
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Table 1 | Experimental stroke models and mortality rates in aged rats.
Strain MCA occlusion Age (mo) Ischemia Mortality (%) Localization Anesthetic Reference
Wistar Thermocoagulation 32 Permanent NA Neocortical Halothane Davis et al. (1995)
Wistar Intraluminal nylon
monoﬁlament
27 Permanent or
reversible
10 Necortical &
striatal
Halothane Sutherland et al. (1996)
Wistar Photothrombosis 24 Permanent 4 Neocortical Halothane Zhao et al. (2005)
Fischer Photothrombosis
non-localized
24 Reversible 16 Neocortical Chloral
hydrate
Futrell et al. (1991)
Wistar Photothrombosis 24 Permanent 4 Neocortical Halothane Zhao et al. (2005)
Wistar Endothelin-1 20–23 Reversible 13.3 Neocortical Isoﬂurane Soleman et al. (2010)
Wistar ECA embolization 18–20 Spontaneous
reperfusion
33 Necortical &
striatal
Isoﬂurane Zhang et al. (2013)
Sprague-Dawley (m) Vascular clip/hook 18–20 Reversible 25 Neocortical Halothane Popa-Wagner et al. (1998)
Sprague-Dawley (f) ECA embolization 18 rt-PA
reperfusion
33 Neocortical Ketamine Dinapoli et al. (2006)
Wistar ECA embolization 18 Spontaneous
reperfusion
47 Necortical &
striatal
Halothane Zhang et al. (2005)
NA, not assessed; ECA, external carotid artery; f, female; m, male.
Chopp, 2012; Zhang et al., 2014). In clinical practice, physical
therapy is used for stimulating post stroke brain remodeling
(Liepert et al., 2004; Honmou et al., 2012).
Stroke patients regain some of their lost neurological func-
tions during the ﬁrst weeks or months after the stroke, most
likely due to functional reorganization of the lesioned area (Zhang
et al., 2014). In animal models of stroke, complete sponta-
neous recovery may occur in young–adult rats, depending on
the size and location of the ischemic lesion. However, stroke
recovery is delayed and often incomplete in aged rats. While
young–adult rats typically begin to show improvements of neu-
rological function starting by day 2 post stroke, neurological
recovery is hardly detectable in aged rats before days 4 or 5,
and achieve about 75% of the functional improvement observed
in young–adult rats by day 14 (Buchhold et al., 2007). Housing
experimental animals in an enriched environment enhances the
recovery from brain damage both in young–adult and aged ani-
mals (Buchhold et al., 2007). When aged rats were allowed to
recover in an enriched environment, the delay period was short-
ened and behavioral performance was signiﬁcantly improved.
The improvement in task performance positively correlated with
slower infarct development, fewer proliferating astrocytes and
smaller glial scars (Buchhold et al., 2007). Even more effective
rehabilitation of the contralateral forelimb could be achieved by
combining enriched environment with physical training (Hicks
et al., 2007).
STRATEGIES TO IMPROVE FUNCTIONAL NEUROLOGICAL
RECOVERY AND TISSUE REPAIR AFTER STROKE BY CELL
THERAPY
Although rehabilitation is important for improving functional
recovery in the early stages after stroke, it does not provide a
replacement of lost tissue. With this understanding, cell therapies
have initially been implemented with the aim of replacing lost
tissue inhuman strokepatients (Kondziolka et al., 2000; Bang et al.,
2005).
Most clinical studies to date have used neural cells derived
from human fetal donors. The techniques to achieve effective
survival and growth of neural tissues transplanted into the CNS
are meanwhile well established (Dunnett, 2013). Even though
effective, neural grafting has not become a standard treatment
for several reasons including the limited supply of fetal tissue
of human origin and controversies about the beneﬁcial effects
(Morizane et al., 2008). Of the various options, the transplanta-
tion of adult stem and precursor cells, propagated in cell culture,
or the use of inducible pluripotent stem cells (iPSCs) derived
from human patients and trans-differentiated into neural cells,
are reasonable alternatives (Haas et al., 2005; Stoll, 2014). iPSCs
hold great promise for stroke treatment, since they lack ethical
concerns and the risk of graft rejection. However, if and how
the aged brain responds to grafted cells is still vaguely known
unclear.
NEURAL PRECURSOR AND STEM CELLS IN SUBCORTICAL
STROKE
Spontaneous recovery is commonly observed if the infarct is
located in the striatum, a subcortical structure that exhibits a
natural activity-dependent plasticity. In animal models, neurolog-
ical recovery is associated with structural dendritic and synaptic
plasticity in the contralesional striatum (Qin et al., 2014) and
with axonal plasticity in contralesional motor cortex (Reitmeir
et al., 2012). This suggests that spontaneous recovery after a stri-
atal stroke may also be augmented by inputs from contralateral
striatum and could explain why patients with subcortical stroke
are more likely to exhibit spontaneous functional neurological
recovery (Rothrock et al., 1995; Bejot et al., 2008).
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Cell-based therapy augments this endogenous response
(Kokaia and Darsalia, 2011). Thus, human iPSCs implanted
into striatum of young–adult animals at 1 week after MCAO,
protected substantia nigra from atrophy, probably through a
trophic effect via release of survival-promoting growth factors
(Oki et al., 2012; Polentes et al., 2012; Tornero et al., 2013; Yuan
et al., 2013).
How the cells are transplanted and where they are delivered
are important issues in stem cell therapy. Data from many groups
have shown that stroke increases the proliferation of endogenous
neural precursor cells (NPCs) in the ipsilesional subventricular
zone (SVZ) of young–adult rodentswith amaximumat 1–2weeks.
These endogenous NPCs migrated along a scaffold of blood ves-
sels to the peri-infarct striatum over a period of several months
(Darsalia et al., 2007; Kojima et al., 2010). Some NPCs differenti-
ated into medium size spiny neurons and may become part of the
neuronal network (Arvidsson et al., 2002; Jin et al., 2006; Thored
et al., 2006; Hou et al., 2008; Bacigaluppi et al., 2009; Doeppner
et al., 2012; Mine et al., 2013). Noteworthy, the transplanted NPCs
also stimulated neurogenesis in the ipsilateral SVZ and subgran-
ular zone of the dentate gyrus (DG; Jin et al., 2011; Zhang et al.,
2011; Mine et al., 2013).
In subcortical stroke, the location of the ischemic lesion in rela-
tion to the SVZ is thought to play a major role in stroke recovery.
Unfortunately, the proportion of surviving neurons is discour-
agingly low (Arvidsson et al., 2002; Parent et al., 2002). Yet, the
formation of neurons in the striatum is preserved in aged animals.
Thus, the number of new striatal neurons in aged rodents after
stroke was similar to that in young–adult rodents (Darsalia et al.,
2005; Ahlenius et al., 2009), despite 50%decline in neurogenesis in
the SVZ of elderly compared with young–adult animals (Enwere
et al., 2004).
The subventricular cavity is lined up by ependymal cells
that are quiescent and do not contribute to neurogenesis under
normal conditions. However, in response to stroke ependymal
cells enter the cell cycle and generate astrocytes and neurob-
lasts (Carlén et al., 2009). Signaling through the Notch pathway
is required to maintain ependymal cell quiescence and suppresses
neuronal differentiation and forced Notch signaling blocked the
ependymal cell response to stroke (Carlén et al., 2009). However, in
amore recent study ischemia-induced cell proliferation in the SVZ
in aged rodents was enhanced by Notch1 activation and was asso-
ciated with a reduced infarct volume and improved motor deﬁcits
(Wang et al., 2009; Sun et al., 2013). Conversely, ablation of dou-
blecortin (DCX)-expressing cellswith ganciclovir beforeMCAOin
DCX-TK transgenic mice resulted in an increased infarct size and
an adverse effect on functional outcome from cerebral ischemia
(Jin et al., 2010b). Likewise, disruption of neurogenesis by low
dose of irradiation, which, in part, inhibits DG neurogenesis, is
associated with more severe functional impairments after cerebral
global ischemia in gerbils (Raber et al., 2004).
Studies onpost-mortembrains provided evidence for enhanced
SVZ cell proliferation and neuroblast formation after stroke even
in aged humans (Jin et al., 2006; Macas et al., 2006; Minger et al.,
2007;Martí-Fàbregas et al., 2010). In linewith the observation that
newneurons are continuously formed in the adult human striatum
(Ernst et al., 2014), an increased number of putative neuroblasts
was noted in the human striatum in response to stroke (Macas
et al., 2006).
However, whether endogenous neurogenesis contributes to
spontaneous stroke recovery is still to be established. Human iPSC-
derived long-term neuroepithelial-like stem cells (hiPSC-lt-NES)
derived from a young adult had the potential to survive, differ-
entiate into immature and mature neurons, and migrate to the
peri-infarct tissue,when transplanted into the stroke-injured stria-
tum and cortex in young–adult rats (Oki et al., 2012; Tornero et al.,
2013). Young–adult rats treated with these cells showed improved
neurological recovery as comparedwith animals not receiving such
grafts (Oki et al., 2012; Tornero et al., 2013). Whether iPSC-lt-
NES cells similarly promote neurological recovery in aged rats,
when transplanted into subcortical brain areas, still remains to be
shown.
NEURAL PRECURSOR AND STEM CELLS IN CORTICAL
STROKE
Cortical strokes lack the vicinity of a neurogenic niche like
the SVZ, which impedes brain remodeling processes. Indeed,
the post-acute delivery of adult mouse NPCs does not pre-
vent secondary degeneration in the young–adult mouse cerebral
cortex as much as the striatum, when animals are submitted
to intraluminal MCAO (Bacigaluppi et al., 2009). Despite the
less potent effects on neuronal survival, NPC delivery reduced
glial scar formation in the surrounding of neocortical strokes
(Bacigaluppi et al., 2009) and increased axonal plasticity in the
contralesional motor cortex (Andres et al., 2011). These data con-
vincingly show that the cerebral cortex does respond to restorative
therapies.
If and how the aged brain responds to exogenous NPCs is
poorly understood. The DG is one of the few brain regions to
support neurogenesis in the adult by the recruitment of new
granule cells into the hippocampal circuitry (van Praag et al.,
2002). However, the extent of new granule cell recruitment is
dramatically reduced in middle-aged (12 month-old) and aged
(24 month-old) compared with young–adult (6 week-old) rats
(Heine et al., 2004). The reduced precursor cell proliferation was
not only caused by a general decline in total precursor cell num-
bers, but also by a reduced proliferation of the NPCs (Walter et al.,
2011).
In animal models, focal neocortical infarcts induced prolifera-
tive changes that have been associated with an enhanced number
of newborn neurons in the DG of young–adult but not aged
mice (Walter et al., 2010). Therefore, later studies examined if
exogenous NPC delivery might restore neurogenesis in the DG of
old rodents. To test this hypothesis, NPCs isolated from embry-
onic caudal neural tubes of Sox-2:EGFP transgenic mice were
expanded in vitro and bilaterally injected into the hippocam-
pus of middle-aged (12 month-old) Fisher-344 rats (Hattiangady
et al., 2007). Grafted NPCs migrated to all layers of the hip-
pocampus and enhanced the number of new dentate granule cells.
Increased dentate neurogenesis, measured by DCX staining in the
aging hippocampus following grafting likely reﬂected a more con-
ducive microenvironment for proliferation of endogenous NPCs
in the presence of grafts of exogenous NPCs (Hattiangady et al.,
2007). In another study, intracerebroventricular administration
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of conditionally immortalized human fetal brain (CTX0E03) cells
in 22 month-old rats, stimulated the proliferation of NPCs in the
subgranular zone of the DG as demonstrated by immunohisto-
chemical staining for the immature neuronal marker DCX (Park
et al., 2010).
Most previous studies of NPC transplantation in rodents
have employed post-ischemic intervals of 1 week or less. How-
ever, the option for delayed treatment is clinically important.
In aged (24 month-old) Sprague-Dawley rats, transplantation of
human embryonic stem cell (hESC)-derived NPCs integrated into
Matrigel scaffolds reduced ischemic infarct volume and improved
neurological recovery even when implanted into the cavity of
neocortical infarcts as late as 3 weeks after stroke (Jin et al.,
2010a). In a subsequent study, the transplantation of human
NPCs together with Matrigel into the lesioned neocortex of young
adult (3 month-old) and aged (24 month-old) male Fisher-344
rats at 2 weeks after stroke stimulated neurogenesis in the SVZ
ipsilateral to stroke, as demonstrated by increased numbers of
cells expressing the early neuronal lineage marker Dcx at 60 days
post-transplantation (Jin et al., 2011).
In a recent study, human iPSC transplanted directly into the
damaged neocortex of aged rats survived, differentiated into
neurons and improved functional recovery in cylinder test at 4
and 7 weeks (Tatarishvili et al., 2014). The grafted hiPSC sup-
pressed microglia/macrophage activation in the stroke-injured
cortex as evidenced by differential morphological changes of these
cells in the cell-grafted and vehicle-injected animals (Tatarishvili
et al., 2014). Although it is not clear how microglia/macrophages
were affected at earlier time-points after stroke, it seems possi-
ble that the observed immunomodulatory action of the grafts
could contribute to both neuroprotective and plasticity responses.
Consistent with our ﬁndings, previous studies have shown that
human fetal NPCs transplanted into cortex or striatum reduced
the number of microglia/macrophages in the peri-infarct tissue
1, 6, and 14 weeks after stroke (Horie et al., 2011; Mine et al.,
2013). Similarly, inhibition of microglial activation has also been
reported in ischemic mice following systemic delivery of mouse
NPCs (Bacigaluppi et al., 2009).
Inducible pluripotent cells generated fromhumanﬁbroblasts of
aged humans may be differentiated into speciﬁc cell types, namely
into functional motor cortical neurons (Mohamad et al., 2013;
Phanthong et al., 2013). Interestingly, the differentiation capacity
into motor cortical neurons was the same for iPSCs obtained from
29 and 82 year-old individuals (Boulting et al., 2011).
MESENCHYMAL STEM CELLS IN STRIATAL AND
NEOCORTICAL STROKE
Patients with cerebrovascular diseases have decreased numbers of
circulating bone marrow-derived CD34+ precursor cells, which
have been suggested to have prognostic value for neurologic func-
tion in patients with history of brain infarction (Taguchi et al.,
2009). These ﬁndings have prompted experiments aiming at the
restoration of circulating bone marrow-derived precursor cells
in stroke models by transplantation of autologous hematopoietic
progenitor cells.
Mesenchymal stem cells (MSC) derived either from bone mar-
row or adipose tissue have repeatedly been shown to ameliorate
neurological recovery in experimental stroke models (Schwart-
ing et al., 2008; Honmou et al., 2012; Kocsis and Honmou, 2012).
When administered in the acute stroke phase, MSCs decreased
infarct volume, improved neurological function, enhanced neu-
rogenesis, and exerted anti-inﬂammatory actions. MSCs enhance
recovery processes in the injured brain by promoting angiogenesis,
neurogenesis, and neural reorganization (Hayase et al., 2009; Bao
et al., 2011; Lim et al., 2011; Hsieh et al., 2013).
Improved neurological recovery associated with preservation
of pyramidal tract axons ipsilateral to the stroke have also been
described in 12-month-old ischemic rats systemically treated with
bone marrow-derived MSCs (Shen et al., 2007). Neurological
improvements persisted for at least 1 year (Shen et al., 2007).
When delivered to 12-month-old ischemic rats, the improve-
ment of neurological recovery and reduction of infarct volume
induced by autologous bone marrow-derived MSC transplanta-
tion resembled that in 2–3-month-old rats (Brenneman et al.,
2010), indicating that aging does not impair the responsiveness
to MSC therapy. This was particularly noteworthy as the num-
ber of transplanted cells in the peri-infarct tissue decreased within
hours andwere almost undetectable after 7 days (Brenneman et al.,
2010).
Similar to bone marrow-derived cells, umbilical cord-derived
blood cells (UCBCs) are widely available, representing an attrac-
tive source for cell-based therapies. Human UCBCs are rich in
mesenchymal and endothelial precursor cells and can be col-
lected without the ethical concerns associated with embryonic or
fetal cells. Intravenous injection of human UCBCs in aged (20-
month-old) rats restored the age-related decrease of endogenous
neurogenesis and reduced brain inﬂammation (Bachstetter et al.,
2008). In young–adult rats exposed to focal cerebral ischemia,
intravenous delivery of CD34+ UCBCs enhanced endogenous
angiogenesis, neurogenesis and functional neurological recovery
in some (Chen et al., 2001; Taguchi et al., 2004a,b), but not other
(Mäkinen et al., 2006) studies. In aged (18–20-month-old) rats
exposed to focal cerebral ischemia, intravenous delivery of human
umbilical tissue-derived cells improved functional neurological
recovery and increased angiogenesis and synaptogenesis (Zhang
et al., 2013). This suggests that umbilical cells may be used for
stroke treatment in the aged ischemic brain.
Basedon these observations, further clinical studies using intra-
venously delivered MSCs have been initiated in human stroke
subjects (Lee et al., 2010; Moniche et al., 2012). Transplantation
of autologous bone marrow-derived MSCs in pilot studies has
been proven safe in human patients with acute middle cerebral
artery infarcts (Bang et al., 2005; Battistella et al., 2011; Savitz
et al., 2011; Friedrich et al., 2012; Moniche et al., 2012; Banerjee
et al., 2014). Moreover, improvements of neurological recov-
ery were noted (Bang et al., 2005; Battistella et al., 2011; Savitz
et al., 2011; Friedrich et al., 2012; Moniche et al., 2012; Banerjee
et al., 2014). Unfortunately, these studies lacked appropriate con-
trol groups, which limits conclusions around the efﬁcacy of cell
therapy.
In the translation of studies from bench to bedside, care should
be taken that not only aging, but also age-related co-morbidities
may affect brain remodeling and responses to cell-based therapies.
Thus, the delivery of bone marrow-derived MSCs did not improve
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neurological recovery in rats exhibiting streptozotocin-induced
type I diabetes, but increased mortality, blood–brain barrier leak-
age and brain hemorrhage (Chen et al., 2011). Besides, excessive
angiogenesis was noted in diabetic rats receiving MSCs that was
associated with cerebral arteriole narrowing and neointima for-
mation inside the internal carotid artery (Chen et al., 2011). In
histochemical studies, increased macrophage accumulation was
noted in blood vessels of diabetic MSC treated rats. The authors
suggested thatMSC treatment shouldnot be considered in diabetic
patients.
Not only type I diabetes, but also hyperlipidemia may affect
post-ischemic brain remodeling, as shown in studies showing the
attenuation of VEGF-induced angiogenesis in ischemic ApoE−/−
mice receiving Western diet (Zechariah et al., 2013), presumably
via internalization and degradation of VEGF receptor-2 (Jin et al.,
2013). Further studies identifying the conditions of efﬁcacy and
safety of cell-based therapy under conditions of vascular risk
factors and diseases are warranted.
CO-TRANSPLANTATION STRATEGIES AND COMBINATION
THERAPIES
Poor survival and differentiation of both the transplanted cells and
their progenies in the inhospitable environment of the infarcted
cortex has prompted the search for alternatives and new concepts
like the neurovascular unit to limit the loss of transplanted cells.
To this end cotransplantation of endothelial cells with NPCs in a
mouse model of stroke enhanced the survival, proliferation, and
differentiation of transplanted cells and improved functional neu-
rological recovery (Nakagomi et al., 2009). Even more challenging,
cotransplantation of mouse embryonic stem cell-derived vascular
progenitor cells (VPCs) with NPCs after ischemic stroke produced
not only neural cells but also endothelial cells and pericytes, thus
providing nearly all important components for recovery of the
neurovascular unit, i.e., neurons, astroglia, endothelial cells, and
mural vascular cells (Li et al., 2014).
Granulocyte colony stimulating factor (G-CSF) has been par-
ticularly successful when used to improve neurological function
in various types of focal cerebral ischemia in young–adult animals
(Shyu et al., 2004; Schäbitz and Schneider, 2007). We have recently
been able to show that G-CSF treatment in 20-month-old aged
rats enhances animal survival, improved functional neurological
recovery, and induced neurogenesis in the ipsilesional SVZ (Popa-
Wagner et al., 2010). Next, we reasoned that the efﬁciency of the
bone marrow-derived-cell therapy may be increased by simulta-
neous application of G-CSF. In particular, we tested the hypothesis
that grafting of pre-differentiated bone marrow-derived MSCs
in G-CSF-treated animals would improve long term functional
outcome in aged rodents (Balseanu et al., 2014). Although the
combination therapy signiﬁcantly improved neurological recov-
ery and increased microvessel density in the former infarct core,
neither G-CSF nor the combination decreased animal mortality,
reduced infarct volume or increased neurogenesis (Balseanu et al.,
2014).
The mechanisms by which MSCs may ameliorate infarcted
brain tissue seem related more to the capacity of MSCs to release
neuroprotective factors (paracrine action) than to their capac-
ity to replace damaged neural cells. Thus, around the former
infarct core, several groups noted vigorous angiogenesis as evi-
denced by BrdU-positive endothelial cells (reviewed in Bronckaers
et al., 2014). In our study, the density of the newly formed blood
vessels was signiﬁcantly higher in the brains of aged animals
treated with the combination of G-CSF and MSCs as compared
to controls and G-CSF, but not MSCs alone (Balseanu et al., 2014;
Figure 1).
CONCLUSION
Taken together,
(i) the restorative potential of the brain is preserved in aged,
ischemic animals, although speciﬁc age-related aspects appear
to exist related to the accelerated progression of infarction, the
decreased proliferation of endogenous NPCs and the delayed ini-
tiation of neurological recovery (Zhang et al., 2013; Balseanu et al.,
2014),
(ii) the environment of the aged brain does not preclude
effects of grafted NPCs, MSCs, or iPSCs on brain remodeling,
endogenous neurogenesis and functional neurological recovery,
FIGURE 1 | Delivery of bone marrow-derived MSCs in aged rats
exposed to focal cerebral ischemia. (A) Administration of MSCs in
the acute stroke phase via the jugular vein, brain infarcts being
detected by MRI; (B) histochemical analysis of CD166+ cells (green) in
the infarcted area, where ∼1% of injected MSCs were found
intermingled with NeuN+ neurons (green); (C) angiogenesis as revealed
by rat endothelial cell antigen (RECA; purple)/BrdU (blue)
immunostaining. Basal laminae were counterstained with antibody
against laminin (LM; green; modiﬁed based on Balseanu et al., 2014).
Scale bar, 20 μm.
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(iii) detrimental consequences may result from age-related vas-
cular co-morbidities, namely from diabetes or hyperlipidemia,
in which maladaptive or impaired brain remodeling has been
described,
(iv) although endogenous neurogenesis has been observed,
even in aged humans, questions remain regarding the functional
relevance of newly formed neurons for stroke recovery in human
patients, where distances between endogenous stem cell niches
and stroke injuries are so much larger due to the bigger size of
the brain. Further research must explore optimal transplanta-
tion protocols (Dailey et al., 2013). Fascinating possibilities have
recently been identiﬁed in the transdifferentiation capacity of
iPSCs to speciﬁc neuronal subtypes, which might open new per-
spectives for cell replacement therapy. Whether such strategies
may at all contribute to functional neurological recovery, remains
unclear.
ACKNOWLEDGMENTS
This work was supported by a grant from the Ministry of
Research and Education of Germany (FKZ01GN0982; to Aurel
Popa-Wagner), by a grant of the Romanian National Authority
for Scientiﬁc Research, CNCS – UEFISCDI (PN-II-PT-PCCA-
2011-3, No 80/2012; to Aurel Popa-Wagner) and by grants of
theDeutsche Forschungsgemeinschaft (HE3173/2-1,HE3173/2-2,
and HE3173/3-1; to Dirk M. Hermann).
REFERENCES
Ahlenius, H., Visan, V., Kokaia, M., Lindvall, O., and Kokaia, Z. (2009). Neural stem
and progenitor cells retain their potential for proliferation and differentiation
into functional neurons despite lower number in aged brain. J. Neurosci. 29,
4408–4419. doi: 10.1523/JNEUROSCI.6003-08.2009
Andres, R. H., Horie, N., Slikker, W., Keren-Gill, H., Zhan, K., Sun, G., et al. (2011).
Human neural stem cells enhance structural plasticity and axonal transport in
the ischaemic brain. Brain 134, 1777–1789. doi: 10.1093/brain/awr094
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., and Lindvall, O. (2002). Neuronal
replacement from endogenous precursors in the adult brain after stroke. Nat.
Med. 8, 963–970. doi: 10.1038/nm747
Ay, H., Koroshetz,W. J., Vangel, M., Benner, T., Melinosky, C., Zhu, M., et al. (2005).
Conversion of ischemic brain tissue into infarction increases with age. Stroke 36,
2632–2636. doi: 10.1161/01.STR.0000189991.23918.01
Bachstetter, A. D., Pabon, M. M., Cole, M. J., Hudson, C. E., Sanberg, P. R., Willing,
A. E., et al. (2008). Peripheral injection of human umbilical cord blood stimulates
neurogenesis in the aged rat brain. BMC Neurosci. 9:22. doi: 10.1186/1471-22
02-9-22
Bacigaluppi, M., Comi, G., and Hermann, D. M. (2010). Animal models of ischemic
stroke. Part two: modeling cerebral ischemia. Open Neurol. J. 4, 34–38. doi:
10.2174/1874205X01004020026
Bacigaluppi, M., Pluchino, S., Jametti, L. P., Kilic, E., Kilic, U., Salani, G., et al.
(2009). Delayed post-ischaemic neuroprotection following systemic neural stem
cell transplantation involves multiple mechanisms. Brain 132, 2239–2251. doi:
10.1093/brain/awp174
Badan, I., Buchhold, B., Hamm, A., Gratz, M., Walker, L. C., Platt, D.,
et al. (2003). Accelerated glial reactivity to stroke in aged rats correlates with
reduced functional recovery. J Cereb. Blood Flow Metab. 23, 845–854. doi:
10.1097/01.WCB.0000071883.63724.A7
Balseanu, A. T., Buga, A. M., Catalin, B., Wagner, D. C., Boltze, J., Zagrean, A. M.,
et al. (2014). Multimodal approaches for regenerative stroke therapies: combina-
tion of granulocyte colony-stimulating factor with bone marrow mesenchymal
stem cells is not superior to G-CSF alone. Front. Aging Neurosci. 6:130. doi:
10.3389/fnagi.2014.00130
Banerjee, S., Bentley, P., Hamady, M., Marley, S., Davis, J., and Shlebak, A.
(2014). Intra-Arterial immunoselected CD34+ stem sells for acute ischemic
stroke. Stem Cells Transl. Med. doi: 10.5966/sctm.2013-0178 [Epub ahead of
print].
Bang, O. Y., Lee, J. S., Lee, P. H., and Lee, G. (2005). Autologous mesenchymal
stem cell transplantation in stroke patients. Ann. Neurol. 57, 874–882. doi:
10.1002/ana.20501
Bao, X., Wei, J., Feng, M., Lu, S., Li, G., Dou, W., et al. (2011). Transplantation
of human bone marrow-derived mesenchymal stem cells promotes behavioral
recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res.
1367, 103–113. doi: 10.1016/j.brainres.2010.10.063
Battistella, V., de Freitas, G. R., da Fonseca, L. M., Mercante, D., Gutﬁlen, B.,
Goldenberg, R. C., et al. (2011). Safety of autologous bone marrow mononuclear
cell transplantation in patients with nonacute ischemic stroke. Regen. Med. 6,
45–52. doi: 10.2217/rme.10.97
Bejot, Y., Catteau, A., Caillier, M., Rouaud, O., Durier, J., Marie, C., et al. (2008).
Trends in incidence, risk factors, and survival in symptomatic lacunar stroke in
Dijon, France, from 1989 to 2006: a population-based study. Stroke 39, 1945–
1951. doi: 10.1161/STROKEAHA.107.510933
Boulting, G. L., Kiskinis, E., Croft, G. F., Amoroso, M. W., Oakley, D. H.,Wainger, B.
J., et al. (2011). A functionally characterized test set of human induced pluripotent
stem cells. Nat. Biotechnol. 29, 279–286. doi: 10.1038/nbt.1783
Brenneman, M., Sharma, S., Harting, M., Strong, R., Cox, C. S. Jr., Aronowski, J.,
et al. (2010). Autologous bone marrow mononuclear cells enhance recovery after
acute ischemic stroke in young and middle-aged rats. J. Cereb. Blood Flow Metab.
30, 140–149. doi: 10.1038/jcbfm.2009.198
Bronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., Struys, T., et al.
(2014). Mesenchymal stem/stromal cells as a pharmacological and therapeu-
tic approach to accelerate angiogenesis. Pharmacol. Ther. 143, 181–196. doi:
10.1016/j.pharmthera.2014.02.013
Buchhold, B., Mogoanta, L., Suofu, Y., Hamm, A., Walker, L., Kessler, Ch., et al.
(2007). Environmental enrichment improves functional and neuropathological
indices following stroke in young and aged rats. Restor. Neurol. Neurosci. 25,
467–484.
Carlén, M., Meletis, K., Göritz, C., Darsalia, V., Evergren, E., Tanigaki, K., et al.
(2009). Forebrain ependymal cells areNotch-dependent and generate neuroblasts
and astrocytes after stroke. Nat. Neurosci. 12, 259–267. doi: 10.1038/nn.2268
Chen, J., Sanberg, P. R., Li, Y., Wang, L., Lu, M., Willing, A. E., et al. (2001).
Intravenous administration of human umbilical cord blood reduces behavioral
deﬁcits after stroke in rats. Stroke 32, 2682–2688. doi: 10.1161/hs1101.098367
Chen, J., Ye, X., Yan, T., Zhang, C., Yang, X. P., Cui, X., et al. (2011). Adverse
effects of bone marrow stromal cell treatment of stroke in diabetic rats. Stroke 42,
3551–3558. doi: 10.1161/STROKEAHA.111.627174
Dailey, T., Metcalf, C., Mosley, Y. I., Sullivan, R., Shinozuka, K., Tajiri, N., et al.
(2013). An update on translating stem cell therapy for stroke from bench to
bedside. J. Clin. Med. 2, 220–241. doi: 10.3390/jcm2040220
Darsalia, V., Heldmann, U., Lindvall, O., and Kokaia, Z. (2005). Stroke-
induced neurogenesis in aged brain. Stroke 36, 1790–1795. doi: 10.1161/01.
STR.0000173151.36031.be
Darsalia, V., Kallur, T., and Kokaia, Z. (2007). Survival, migration and neuronal
differentiation of human fetal striatal and cortical neural stem cells grafted in
stroke-damaged rat striatum. 1193903071 Eur. J. Neurosci. 26, 605–614. doi:
10.1111/j.1460-9568.2007.05702.x
Davis, M., Mendelw, A. D., Perry, R. H., Chambers, I. R., and James, O. F. (1995).
Experimental stroke and neuroprotection in the aging rat brain. Stroke 26, 1072–
1078. doi: 10.1161/01.STR.26.6.1072
Dinapoli, V. A., Rosen, C. L., Nagamine, T., and Crocco, T. (2006). Selective MCA
occlusion: a precise embolic stroke model. J. Neurosci. Methods 154, 233–238.
doi: 10.1016/j.jneumeth.2005.12.026
Doeppner, T. R., Ewert, T. A., Tönges, L., Herz, J., Zechariah, A., ElAli, A., et al.
(2012). Transduction of neural precursor cells with TAT-heat shock protein
70 chaperone: therapeutic potential against ischemic stroke after intrastri-
atal and systemic transplantation. Stem Cells 30, 1297–1310. doi: 10.1002/ste
m.1098
Dunnett, S. B. (2013). Neural tissue transplantation, repair, and rehabilitation.
Handb. Clin. Neurol. 110, 43–59. doi: 10.1016/B978-0-444-52901-5.00004-6
Enwere, E., Shingo, T., Gregg, C., Fujikawa, H., Ohta, S., and Weiss, S.
(2004). Aging results in reduced epidermal growth factor receptor signal-
ing, diminished olfactory neurogenesis. J. Neurosci. 24, 8354–8365. doi:
10.1523/JNEUROSCI.2751-04.2004
Ernst, A., Alkass, K., Bernard, S., Salehpour, M., Perl, S., Tisdale, J., et al. (2014).
Neurogenesis in the striatum of the adult human brain. Cell 156, 1072–1083. doi:
10.1016/j.cell.2014.01.044
Frontiers in Cellular Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 347 | 7
Popa-Wagner et al. Cell therapy of stroke
Feigin, V. L., Lawes, C. M., Bennett, D. A., and Anderson, C. S. (2003). Stroke
epidemiology: a review of population-based studies of incidence, prevalence, and
case-fatality in the late 20th century. Lancet Neurol. 2, 43–53. doi: 10.1016/S1474-
4422(03)00266-7
Friedrich, M. A., Martins, M. P., Arau´jo, M. D., Klamt, C., Vedolin, L., Garicochea,
B., et al. (2012). Intra-arterial infusion of autologous bone-marrow mononuclear
cells in patients with moderate to severe middle-cerebral-artery acute ischemic
stroke. Cell Transplant. 21(Suppl. 1), S13–S21. doi: 10.3727/096368912X612512
Futrell, N., Garcia, J. H., Peterson, E., and Millikan, C. (1991). Embolic stroke in
aged rats. Stroke 22, 1582–1591. doi: 10.1161/01.STR.22.12.1582
Gokcay, F., Arsava, E. M., Baykaner, T., Vangel, M., Garg, P., Wu, O., et al. (2011).
Age-dependent susceptibility to infarct growth in women. Stroke 42, 947–951.
doi: 10.1161/STROKEAHA.110.603902
Haas, S.,Weidner, N., and Winkler, J. (2005). Adult stem cell therapy in stroke. Curr.
Opin. Neurol. 18, 59–64. doi: 10.1097/00019052-200502000-00012
Hallett, M. (2001). Plasticity of the human motor cortex and recovery from stroke.
Brain Res. Rev. 36, 169–174. doi: 10.1016/S0165-0173(01)00092-3
Hattiangady, B., Shuai, B., Cai, J., Coksaygan, T., Rao, M. S., and Shetty, A. K.
(2007). Increaseddentate neurogenesis after graftingof glial restrictedprogenitors
or neural stem cells in the aging hippocampus. Stem Cells 25, 2104–2117. doi:
10.1634/stemcells.2006-0726
Hayase, M., Kitada, M., Wakao, S., Itokazu, Y., Nozaki, K., Hashimoto, N., et al.
(2009). Committed neural progenitor cells derived from genetically modiﬁed
bone marrow stromal cells ameliorate deﬁcits in a rat model of stroke. J. Cereb.
Blood Flow Metab. 29, 1409–1420. doi: 10.1038/jcbfm.2009.62
Heine, V. M., Maslam, S., Joëls, M., and Lucassen, P. J. (2004). Prominent
decline of newborn cell proliferation, differentiation, and apoptosis in the
aging dentate gyrus, in absence of an age-related hypothalamus-pituitary-adrenal
axis activation. Neurobiol. Aging 25, 361–375. doi: 10.1016/S0197-4580(03)0
0090-3
Hermann, D. M., and Chopp, M. (2012). Promoting brain remodelling and plas-
ticity for stroke recovery: therapeutic promise and potential pitfalls of clinical
translation. Lancet Neurol. 11, 369–380. doi: 10.1016/S1474-4422(12)70039-X
Hicks, A. U., Hewlett, K., Windle, V., Chernenko, G., Ploughman, M., Jolkkonen, J.,
et al. (2007). Enriched environment enhances transplanted subventricular zone
stem cell migration and functional recovery after stroke. Neuroscience 146, 31–40.
doi: 10.1016/j.neuroscience.2007.01.020
Honmou, O., Onodera, R., Sasaki, M., Waxman, S. G., and Kocsis, J. D. (2012).
Mesenchymal stem cells: therapeutic outlook for stroke. Trends Mol. Med. 18,
292–297. doi: 10.1016/j.molmed.2012.02.003
Horie, N., Pereira, M. P., Niizuma, K., Sun, G., Keren-Gill, H., Encarnacion, A., et al.
(2011). Transplanted stem cell-secreted vascular endothelial growth factor effects
poststroke recovery, inﬂammation, and vascular repair. Stem Cells 29, 274–285.
doi: 10.1002/stem.584
Hou, S. W., Wang, Y. Q., Xu, M., Shen, D. H., Wang, J. J., Huang, F.,
et al. (2008). Functional integration of newly generated neurons into stria-
tum after cerebral ischemia in the adult rat brain. Stroke 39, 2837–2844. doi:
10.1161/STROKEAHA.107.510982
Hsieh, J.-Y., Wang, H.-W., Chang, S.-J., Liao, K.-H., Lee, I.-H., Lin, W. S., et al.
(2013). Mesenchymal stem cells fromhumanumbilical cord express preferentially
secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS
ONE 8:e72604. doi: 10.1371/journal.pone.0072604
Jin, F., Hagemann, N., Brockmeier, U., Schäfer, S. T., Zechariah, A., and Hermann,
D. M. (2013). LDL attenuates VEGF-induced angiogenesis via mechanisms
involving VEGFR2 internalization and degradation following endosome-trans-
Golgi network trafﬁcking. Angiogenesis 16, 625–637. doi: 10.1007/s10456-013-
9340-2
Jin, K., Mao, X., Xie, L., Greenberg, R. B., Peng, B., Moore, A., et al. (2010a). Delayed
transplantation of human neural precursor cells improves outcome from focal
cerebral ischemia in aged rats. Aging Cell 9, 1076–1083. doi: 10.1111/j.1474-
9726.2010.00638.x
Jin, K., Wang, X., Xie, L., Mao, X. O., and Greenberg, D. A. (2010b). Transgenic
ablation of doublecortin-expressing cells suppresses adult neurogenesis andwors-
ens stroke outcome in mice. Proc. Natl. Acad. Sci. U.S.A. 27, 7993–7998. doi:
10.1073/pnas.1000154107
Jin, K., Wang, X., Xie, L., Mao, X. O., Zhu, W., Wang, Y., et al. (2006). Evidence
for stroke-induced neurogenesis in the human brain. Proc. Natl. Acad. Sci. U.S.A.
103, 13198–13202. doi: 10.1073/pnas.0603512103
Jin, K., Xie, L., Mao, X., Greenberg, M. B., Moore, A., Peng, B., et al. (2011).
Effect of human neural precursor cell transplantation on endogenous neuro-
genesis after focal cerebral ischemia in the rat. Brain Res. 1374, 56–62. doi:
10.1016/j.brainres.2010.12.037
Katsman, D., Zheng, J., Spinelli, K., and Carmichael, S. T. (2003). Tissue microenvi-
ronments within functional cortical subdivisions adjacent to focal stroke. J. Cereb.
Blood Flow Metab. 23, 997–1009. doi: 10.1097/01.WCB.0000084252.20114.BE
Kocsis, J. D., and Honmou, O. (2012). Bone marrow stem cells in experimental
stroke. Prog. Brain Res. 201, 79–98. doi: 10.1016/B978-0-444-59544-7.00005-6
Kojima, T., Hirota, Y., Ema, M., Takahashi, S., Miyoshi, I., Okano, H., et al.
(2010). Subventricular zone-derived neural progenitor cellsmigrate along a blood
vessel scaffold toward the post-stroke striatum. Stem Cells 28, 545–554. doi:
10.1002/stem.306
Kokaia, Z., and Darsalia, V. (2011). Neural stem cell-based therapy for ischemic
stroke. Transl. Stroke Res. 2, 272–278. doi: 10.1007/s12975-011-0100-6
Kondziolka, D., Wechsler, L., Goldstein, S., Meltzer, C., Thulborn, K. R., Gebel, J.,
et al. (2000). Transplantation of cultured human neuronal cells for patients with
stroke. Neurology 55, 565–569. doi: 10.1212/WNL.55.4.565
Lee, J. S., Hong, J. M., Moon, G. J., Lee, P. H., Ahn, Y. H., and Bang, O. Y. (2010).
A long-term follow-up study of intravenous autologous mesenchymal stem cell
transplantation in patients with ischemic stroke. Stem Cells 28, 1099–1106. doi:
10.1002/stem.430
Li, J., Tang, Y., Wang, Y., Tang, R., Jiang, W., Yang, G. Y., et al. (2014). Neurovascular
recovery via cotransplanted neural and vascular progenitors leads to improved
functional restoration after ischemic stroke in rats. Stem Cell Rep. 3, 101–114. doi:
10.1016/j.stemcr.2014.05.012
Liepert, J., Hamzei, F., and Weiller, C. (2004). Lesion-induced and training-induced
brain reorganization. Restor. Neurol. Neurosci. 22, 269–277.
Lim, J. Y., Jeong, C. H., Jun, J. A., Kim, S. M., Ryu, C. H., Hou, Y., et al. (2011).
Therapeutic effects of human umbilical cord blood-derived mesenchymal stem
cells after intrathecal administrationby lumbar puncture in a ratmodel of cerebral
ischemia. Stem Cell Res. Ther. 2, 38. doi: 10.1186/scrt79
Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone,
G., et al. (2010). Executive summary: heart disease and stroke statistics—2010
update: a report from the American Heart Association. Circulation 121, 948–954.
doi: 10.1161/CIRCULATIONAHA.109.192666
Macas, J., Nern, C., Plate, K. H., and Momma, S. (2006). Increased generation of
neuronal progenitors after ischemic injury in the aged adult human forebrain. J.
Neurosci. 26, 13114–13119. doi: 10.1523/JNEUROSCI.4667-06.2006
Mäkinen, S., Kekarainen, T., Nystedt, J., Liimatainen, T., Huhtala, T., Närvänen, A.,
et al. (2006). Human umbilical cord blood cells do not improve sensorimotor or
cognitive outcome following transient middle cerebral artery occlusion in rats.
Brain Res. 1123, 207–215. doi: 10.1016/j.brainres.2006.09.056
Martí-Fàbregas, J., Romaguera-Ros, M., Gómez-Pinedo, U., Martínez-Ramírez, S.,
Jiménez-Xarrié, E., Marín, R., et al. (2010). Proliferation in the human ipsi-
lateral subventricular zone after ischemic stroke. Neurology 74, 357–365. doi:
10.1212/WNL.0b013e3181cbccec
Mine, Y., Tatarishvili, J., Oki, K., Monni, E., Kokaia, Z., and Lindvall, O. (2013).
Grafted human neural stem cells enhance several steps of endogenous neuroge-
nesis and improve behavioral recovery after middle cerebral artery occlusion in
rats. Neurobiol. Dis. 52, 191–203. doi: 10.1016/j.nbd.2012.12.006
Minger, S. L., Ekonomou, A., Carta, E. M., Chinoy, A., Perry, R. H., and Ballard,
C. G. (2007). Endogenous neurogenesis in the human brain following cerebral
infarction. Regen. Med. 2, 69–74. doi: 10.2217/17460751.2.1.69
Mohamad, O., Drury-Stewart, D., Song, M., Faulkner, B., Chen, D., Yu, S. P.,
et al. (2013). Vector-free and transgene-free human iPS cells differentiate into
functional neurons and enhance functional recovery after ischemic stroke inmice.
PLoS ONE 23:8. doi: 10.1371/journal.pone.0064160
Moniche, F., Gonzalez, A., Gonzalez-Marcos, J. R., Carmona, M., Piñero,
P., Espigado, I., et al. (2012). Intra-arterial bone marrow mononuclear
cells in ischemic stroke: a pilot clinical trial. Stroke 43, 2242–2244. doi:
10.1161/STROKEAHA.112.659409
Morizane, A., Li, J. Y., and Brundin, P. (2008). From bench to bed: the potential of
stem cells for the treatment of Parkinson’s disease. Cell Tissue Res. 331, 323–336.
doi: 10.1007/s00441-007-0541-0
Nakagomi, N., Nakagomi, T., Kubo, S., Nakano-Doi, A., Saino, O., Takata, M.,
et al. (2009). Endothelial cells support survival, proliferation, and neuronal
differentiation of transplanted adult ischemia-induced neural stem/progenitor
Frontiers in Cellular Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 347 | 8
Popa-Wagner et al. Cell therapy of stroke
cells after cerebral infarction. Stem Cells 27, 2185–2195. doi: 10.1002/
stem.161
Oki, K., Tatarishvili, J., Wood, J., Koch, P., Wattananit, S., Mine, Y., et al. (2012).
Human-induced pluripotent stem cells form functional neurons and improve
recovery after grafting in stroke-damaged brain. Stem Cells 30, 1120–1133. doi:
10.1002/stem.1104
Parent, J. M., Vexler, Z. S., Gong, C., Derugin, N., and Ferriero, D. M. (2002). Rat
forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann.
Neurol. 52, 802–813. doi: 10.1002/ana.10393
Park, D. H., Eve, D. J., Sanberg, P. R., Musso, J. III, Bachstetter, A. D., Wolfson,
A., et al. (2010). Increased neuronal proliferation in the dentate gyrus of aged
rats following neural stem cell implantation. Stem Cells Dev. 19, 175–180. doi:
10.1089/scd.2009.0172
Phanthong, P., Raveh-Amit, H., Li, T., Kitiyanant, Y., and Dinnyes, A. (2013). Is
aging a barrier to reprogramming? Lessons from induced pluripotent stem cells.
Biogerontology 14, 591–602. doi: 10.1007/s10522-013-9455-2
Polentes, J., Jendelova, P., Cailleret, M., Braun, H., Romanyuk, N., Tropel, P.,
et al. (2012). Human induced pluripotent stem cells improve stroke outcome
and reduce secondary degeneration in the recipient brain. Cell Transplant. 21,
2587–2602. doi: 10.3727/096368912X653228
Popa-Wagner, A., Carmichael, S. T., Kokaia, Z., Kessler, C., and Walker, L. C. (2007).
The response of the aged brain to stroke: too much, too soon? Curr. Neurovasc.
Res. 4, 216–227. doi: 10.2174/156720207781387213
Popa-Wagner, A., Schroder, E., Walker, L. C., and Kessler, C. (1998). β-Amyloid
precursor protein and β-amyloid peptide immunoreactivity in the rat brain
after middle cerebral artery occlusion: effect of age. Stroke 29, 2196–2202. doi:
10.1161/01.STR.29.10.2196
Popa-Wagner, A., Stocker, K., Balseanu, A. T., Rogalewski, A., Diederich, K.,
Minnerup, J., et al. (2010). Effects of granulocyte-colony stimulating factor
after stroke in aged rats. Stroke 41, 1027–1031. doi: 10.1161/STROKEAHA.109.
575621
Qin, L., Jing, D., Parauda, S., Carmel, J., Ratan, R. R., Lee, F. S., et al. (2014). An
adaptive role for BDNF Val66Met polymorphism in motor recovery in chronic
stroke. J. Neurosci. 34, 2493–2502. doi: 10.1523/JNEUROSCI.4140-13.2014
Raber, J., Fan, Y., Matsumori, Y., Liu, Z., Weinstein, P. R., Fike, J. R., et al. (2004).
Irradiation attenuates neurogenesis and exacerbates ischemia-induced deﬁcits.
Ann. Neurol. 55, 381–389. doi: 10.1002/ana.10853
Reitmeir, R., Kilic, E., Reinboth, B. S., Guo, Z., ElAli, A., Zechariah, A., et al. (2012).
Vascular endothelial growth factor induces contralesional corticobulbar plasticity
and functional neurological recovery in the ischemic brain. Acta Neuropathol.
123, 273–284. doi: 10.1007/s00401-011-0914-z
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D.,
Borden, W. B., et al. (2012). Heart disease and stroke statistics-2012 update:
a report from the American Heart Association. Circulation 125, e2–e220. doi:
10.1161/CIR.0b013e31823ac046
Rothrock, J. F., Clark, W. M., and Lyden, P. D. (1995). Spontaneous
early improvement following ischemic stroke. Stroke 26, 1358–1360. doi:
10.1161/01.STR.26.8.1358
Savitz, S. I., Misra, V., Kasam, M., Juneja, H., Cox, C. S. Jr., Alderman, S., et al.
(2011). Intravenous autologous bone marrow mononuclear cells for ischemic
stroke. Ann. Neurol. 70, 59–69. doi: 10.1002/ana.22458
Schäbitz, W. R., and Schneider, A. (2007). New targets for established protein:
exploring G-CSF for the treatment of stroke. Trends Pharmacol. Sci. 28, 157–161.
doi: 10.1016/j.tips.2007.02.007
Schwarting, S, Litwak, S., Hao, W., Baehr, M., Weise, J., and Neu-
mann, H. (2008). Hematopoietic stem cells reduce postischemic inﬂam-
mation and ameliorate ischemic brain injury. Stroke 39, 2867–2875. doi:
10.1161/STROKEAHA.108.513978
Shen, L. H., Li, Y., Chen, J., Cui, Y., Zhang, C., Kapke, A., et al. (2007). One-year
follow-up after bone marrow stromal cell treatment in middle-aged female rats
with stroke. Stroke 38, 2150–2156. doi: 10.1161/STROKEAHA.106.481218
Shyu, W. C., Lin, S. Z., Yang, H. I., Tzeng, Y. S., Pang, C. Y., Yen, P.
S., et al. (2004). Functional recovery of stroke rats induced by granulocyte
colony-stimulating factor-stimulated stem cells. Circulation 110, 1847–1854. doi:
10.1161/01.CIR.0000142616.07367.66
Soleman, S., Yip, P., Leasure, J. L., and Moon, L. (2010). Sustained sensorimotor
impairments after endothelin-1 induced focal cerebral ischemia (stroke) in aged
rats. Exp. Neurol. 222, 13–24. doi: 10.1016/j.expneurol.2009.11.007
Stoll, E. A. (2014). Advances toward regenerative medicine in the central nervous
system: challenges in making stem cell therapy a viable clinical strategy. Mol. Cell.
Ther. 2, 12. doi: 10.1186/2052-8426-2-12
Sun, F., Mao, X., Xie, L., Ding, M., Shao, B., and Jin, K. (2013). Notch1 signaling
modulates neuronal progenitor activity in the subventricular zone in response to
aging and focal ischemia. Aging Cell 12, 978–987. doi: 10.1111/acel.12134
Sutherland, G. R., Dix, G. A., and Auer, R. N. (1996). Effect of age in
rodent models of focal and forebrain ischemia. Stroke 27, 1663–1667. doi:
10.1161/01.STR.27.9.1663
Tacutu, R., Budovsky, A., and Fraifeld, V. E. (2010). The NetAge database: a com-
pendium of networks for longevity, age-related diseases and associated processes.
Biogerontology 11, 513–522. doi: 10.1007/s10522-010-9265-8
Tacutu, R., Budovsky, A., Yanai, H., and Fraifeld, V. E. (2011). Molecular links
between cellular senescence, longevity and age-related diseases-a systems biology
perspective. Aging (Albany N.Y.) 3, 1178–1191.
Taguchi, A., Matsuyama, T., Moriwaki, H., Hayashi, T., Hayashida, K.,
Nagatsuka, K., et al. (2004a). Circulating CD34-positive cells provide an
index of cerebrovascular function. Circulation 109, 2972–2975. doi: 10.1161/
01.CIR.0000133311.25587.DE
Taguchi, A., Soma, T., Tanaka, H., Kanda, T., Nishimura, H., Yoshikawa, H.,
et al. (2004b). Administration of CD34+ cells after stroke enhances neuroge-
nesis via angiogenesis in a mouse model. J. Clin. Invest. 114, 330–338. doi:
10.1172/JCI200420622
Taguchi, A., Nakagomi, N., Matsuyama, T., Kikuchi-Taura, A., Yoshikawa, H., Kasa-
hara, Y., et al. (2009). Circulating CD34-positive cells have prognostic value for
neurologic function in patients with past cerebral infarction. J. Cereb. Blood Flow
Metab. 29, 34–38. doi: 10.1038/jcbfm.2008.92
Taguchi, A., Zhu, P., Cao, F., Kikuchi-Taura, A., Kasahara, Y., Stern, D. M.,
et al. (2011). Reduced ischemic brain injury by partial rejuvenation of bone
marrow cells in aged rats. J. Cereb. Blood. Flow. Metab. 31, 855–867. doi:
10.1038/jcbfm.2010.165
Tatarishvili, J., Oki, K., Monni, E., Koch, P., Memanishvili, T., Buga, A. M., et al.
(2014). Human inducedpluripotent stemcells improve recovery in stroke-injured
aged rats. Restor. Neurol. Neurosci. 32, 547–558. doi: 10.3233/RNN-140404
Thored, P., Arvidsson, A., Cacci, E., Ahlenius, H., Kallur, T., Ekdahl, C. T., et al.
(2006). Persistent production of neurons from adult brain stem cells during
recovery after stroke. Stem Cells 24, 739–747. doi: 10.1634/stemcells.2005-0281
Tornero, D., Wattananit, S., Gronning-Madsen, M., Koch, P., Wood, J., Tatarishvili,
J., et al. (2013). Human induced pluripotent stem cell-derived cortical neurons
integrate in stroke-injured cortex and improve functional recovery. Brain 136,
3561–3577. doi: 10.1093/brain/awt278
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., and Gage,
F. H. (2002). Functional neurogenesis in the adult hippocampus. Nature 415,
1030–1034. doi: 10.1038/4151030a
Walter, J., Keiner, S., Witte, O. W., and Redecker, C. (2010). Differential
stroke-induced proliferative response of distinct precursor cell subpopulations
in the young and aged dentate gyrus. Neuroscience 169, 1279–1286. doi:
10.1016/j.neuroscience.2010.05.035
Walter, J., Keiner, S., Witte, O. W., and Redecker, C. (2011). Age-related effects on
hippocampal precursor cell subpopulations and neurogenesis. Neurobiol. Aging
32, 1906–1914. doi: 10.1016/j.neurobiolaging.2009.11.011
Wang, X., Mao, X., Xie, L., Greenberg, D. A., and Jin, K. (2009). Involvement
of Notch1 signaling in neurogenesis in the subventricular zone of normal and
ischemic rat brain in vivo. J. Cereb. Blood Flow Metab. 29, 1644–1654. doi:
10.1038/jcbfm.2009.83
Yuan, T., Liao, W., Feng, N. H., Lou, Y. L., Niu, X., Zhang, A. J., et al. (2013).
Human induced pluripotent stem cell-derived neural stem cells survive, migrate,
differentiate, and improve neurologic function in a rat model of middle cerebral
artery occlusion. Stem Cell Res. Ther. 4, 73. doi: 10.1186/scrt224
Zechariah, A., ElAli, A., Hagemann, N., Jin, F., Doeppner, T. R., Helfrich, I., et al.
(2013). Hyperlipidemia attenuates vascular endothelial growth factor-induced
angiogenesis, impairs cerebral blood ﬂow, and disturbs stroke recovery via
decreased pericyte coverage of brain endothelial cells. Arterioscler. Thromb. Vasc.
Biol. 33, 1561–1567. doi: 10.1161/ATVBAHA.112.300749
Zhang, J., Meng, L., Qin, W., Liu, N., Shi, F. D., and Yu, C. (2014). Structural dam-
age and functional reorganization in ipsilesional m1 in well-recovered patients
with subcortical stroke. Stroke 45, 788–793. doi: 10.1161/STROKEAHA.113.
003425
Frontiers in Cellular Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 347 | 9
Popa-Wagner et al. Cell therapy of stroke
Zhang, L., Yi, L., Chopp, M., Kramer, B. C., Romanko, M., Gosiewska, A.,
et al. (2013). Intravenous administration of human umbilical tissue-derived cells
improves neurological function in aged rats after embolic stroke. Cell Transplant.
22, 1569–1576. doi: 10.3727/096368912X658674
Zhang, L., Zhang, R. L., Wang, Y., Zhang, C., Zhang, Z. G., Chopp, M.,
et al. (2005). Functional recovery in aged and young rats after embolic stroke:
treatment with a phosphodiesterase type 5 inhibitor. Stroke 36, 847–852. doi:
10.1161/01.STR.0000158923.19956.73
Zhang, R. L., Chopp, M., Roberts, C., Jia, L., Wei, M., Lu, M., et al. (2011).
Ascl1 lineage cells contribute to ischemia-induced neurogenesis and oligoden-
drogenesis. J. Cereb. Blood Flow Metab. 31, 614–625. doi: 10.1038/jcbfm.
2010.134
Zhao, C.-S., Puurunen, K., Schallert, T., Sivenius, J., and Jolkkonen, J. (2005).
Behavioral effects of photothrombotic ischemic cortical injury in aged rats treated
with the sedative-hypnotic GABAergic drug zopiclone. Behav. Brain Res. 160,
260–266. doi: 10.1016/j.bbr.2004.12.007
Conflict of Interest Statement: The authors declare that the researchwas conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Received: 15 August 2014; accepted: 06 October 2014; published online: 03 November
2014.
Citation: Popa-Wagner A, Buga A-M, Doeppner TR and Hermann DM (2014) Stem
cell therapies in preclinical models of stroke associated with aging. Front. Cell. Neurosci.
8:347. doi: 10.3389/fncel.2014.00347
This article was submitted to the journal Frontiers in Cellular Neuroscience.
Copyright © 2014 Popa-Wagner, Buga, Doeppner and Hermann. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original publica-
tion in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Cellular Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 347 | 10
